Sepsis-3 task force

Sepsis-3 task force
Name	Sepsis-3 task force
Formation	2016
Founder	Donald M. Yealy; Ronald C. Petersen (co-chairs)
Purpose	Revision of sepsis definitions and clinical criteria
Headquarters	United States
Region served	International
Members	Multidisciplinary experts from Society of Critical Care Medicine, European Society of Intensive Care Medicine, American College of Chest Physicians, Infectious Diseases Society of America

Sepsis-3 task force was an international expert panel convened to update consensus definitions for sepsis and septic shock, producing the "Sepsis-3" definitions published in 2016. The task force drew participants from leading institutions such as Johns Hopkins Hospital, Mayo Clinic, Massachusetts General Hospital, University of Oxford, and Karolinska Institutet, and its report influenced clinical guidelines from organizations like the World Health Organization and the Surviving Sepsis Campaign.

Background and formation

The group was formed amid debates following earlier consensus conferences including the 1991 and 2001 definitions convened by stakeholders such as American College of Chest Physicians, Society of Critical Care Medicine, Infectious Diseases Society of America, European Society of Intensive Care Medicine, and academic centers like University of California, San Francisco and Harvard Medical School. Pressure for revision came from epidemiologists at Centers for Disease Control and Prevention and clinicians at Beth Israel Deaconess Medical Center and University of Pittsburgh Medical Center who noted limitations in prior frameworks exemplified in literature from The New England Journal of Medicine and Lancet. The task force assembled experts affiliated with institutions including Stanford University, Yale School of Medicine, Imperial College London, University of Toronto, and Charité – Universitätsmedizin Berlin.

Membership and organization

Membership spanned intensivists, infectious disease specialists, epidemiologists, and statisticians from organizations such as Society of Critical Care Medicine, European Society of Intensive Care Medicine, American Thoracic Society, Infectious Diseases Society of America, and academic centers like University of Pennsylvania, Columbia University, University College London, and Monash University. Leadership included chairs drawn from University of Pittsburgh, University of Washington, Vanderbilt University Medical Center, and collaborating methodologists from Johns Hopkins Bloomberg School of Public Health and Harvard T. H. Chan School of Public Health. The task force organized working groups for data analysis, clinical criteria, and implementation with representation from World Health Organization, Bill & Melinda Gates Foundation collaborators, and registry holders such as National Institutes of Health-funded consortia.

Objectives and methodology

Key objectives mirrored requests from bodies including World Health Organization, Surviving Sepsis Campaign, Centers for Disease Control and Prevention, and specialty societies like American College of Emergency Physicians to produce operational definitions suitable for Intensive Care Medicine and emergency care settings such as Royal College of Emergency Medicine. Methodology combined systematic reviews from sources indexed in PubMed and databases curated by Institute for Health Metrics and Evaluation with large clinical datasets from Veterans Health Administration, National Health Service (England), Australian Institute of Health and Welfare, and multicenter collaborations including FINESS registry and the MIMIC database. Statistical approaches used predictive modeling familiar from work at University of Pennsylvania Perelman School of Medicine and validation studies reported in journals like JAMA and BMJ.

Key recommendations and the Sepsis-3 definitions

The task force recommended replacing the systemic inflammatory response syndrome criteria promulgated by American College of Chest Physicians and Society of Critical Care Medicine with organ dysfunction-based definitions using the Sequential Organ Failure Assessment score developed at European Society of Intensive Care Medicine centers including Hôpital Cochin and Charité – Universitätsmedizin Berlin. The report introduced the quick SOFA (qSOFA) bedside tool for non-ICU settings influenced by research from University of Pittsburgh Medical Center and validated against cohorts from MIMIC database, Vanderbilt University Medical Center, Kaiser Permanente, and Johns Hopkins Hospital. The Sepsis-3 statement defined septic shock with criteria incorporating vasopressor dependence and lactate thresholds, echoing prior physiology work from Massachusetts General Hospital and Mayo Clinic investigators and aligning with guideline bodies like the Surviving Sepsis Campaign.

Impact on clinical practice and research

After publication, major health systems such as NHS (England), Veterans Health Administration, Centers for Medicare & Medicaid Services, and academic hospitals including Brigham and Women's Hospital and Cleveland Clinic revised protocols to incorporate SOFA and qSOFA elements. The Sepsis-3 definitions influenced clinical trials designed by investigators at Duke University, University of California, San Francisco, Mount Sinai Health System, and cooperative groups funded by National Institutes of Health and European Commission (Research) frameworks. Journals including The Lancet Respiratory Medicine, Intensive Care Medicine, and Critical Care Medicine published validation and implementation studies from centers such as University of Toronto, Monash University, University of Melbourne, and Seoul National University Hospital.

Controversies and critiques

Critiques emerged from specialty organizations including American College of Emergency Physicians, American Academy of Pediatrics, and commentators at The BMJ and Annals of Emergency Medicine who argued qSOFA lacked sensitivity in emergency departments studied at University of California, San Francisco and Vanderbilt University Medical Center. Researchers from Johns Hopkins Bloomberg School of Public Health, Harvard Medical School, Yale School of Medicine, and King's College London reported variable performance in pediatric, obstetric, and low-resource settings represented by studies from University of Cape Town, All India Institute of Medical Sciences, and Instituto Nacional de Salud (Peru). Debates involved editors and policy-makers at World Health Organization, Surviving Sepsis Campaign, Centers for Disease Control and Prevention, and healthcare payers such as Centers for Medicare & Medicaid Services regarding diagnostic coding, epidemiology, and benchmarking.

Legacy and subsequent developments

The Sepsis-3 task force catalyzed further guideline updates by organizations such as Surviving Sepsis Campaign, research consortia at National Institutes of Health, and implementation programs within National Health Service (England) and Canadian Institutes of Health Research. Follow-up work by investigators at University of Pittsburgh, Stanford University, Imperial College London, University of Oxford, and Karolinska Institutet produced refinements, alternative scoring systems, and validation studies in specialties represented by American College of Emergency Physicians, American Academy of Pediatrics, and European Society of Intensive Care Medicine. The effort remains referenced in policy documents by World Health Organization, quality frameworks used by Centers for Medicare & Medicaid Services, and educational curricula at institutions such as Harvard Medical School and Johns Hopkins School of Medicine.

Category:Sepsis Category:Medical guidelines